These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4007893)

  • 1. Studies on the possible central and peripheral effects in man of a cholinesterase inhibitor (pyridostigmine).
    Borland RG; Brennan DH; Nicholson AN; Smith PA
    Hum Toxicol; 1985 May; 4(3):293-300. PubMed ID: 4007893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a mu-opioid receptor agonist (codeine phosphate) on visuo-motor coordination and dynamic visual acuity in man.
    Bradley CM; Nicholson AN
    Br J Clin Pharmacol; 1986 Nov; 22(5):507-12. PubMed ID: 3024689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist and inhibitory effects of pyridostigmine at the neuromuscular junction.
    Bradley RJ; Sterz R; Peper K
    Brain Res; 1986 Jun; 376(1):199-203. PubMed ID: 3719368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular responses to pyridostigmine bromide in organotypic spinal cord-muscle culture.
    Drake-Baumann R; Seil FJ; Spencer PS
    J Physiol Paris; 1998; 92(3-4):305-8. PubMed ID: 9789828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light.
    Nicholson AN; Smith PA; Spencer MB
    Br J Clin Pharmacol; 1982 Nov; 14(5):683-90. PubMed ID: 6128019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ingestion of 60 mg pyridostigmine bromide on contrast sensitivity in man.
    Kay CD; Morrison JD
    Hum Toxicol; 1988 Jul; 7(4):347-52. PubMed ID: 3410484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of the central effects of 3-methylclonazepam.
    Darragh A; Lambe R; Brick I; O'Boyle C
    Br J Clin Pharmacol; 1982 Dec; 14(6):871-2. PubMed ID: 6817773
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of the anticholinesterase and anticurare effects of some cholinesterase inhibitors.
    Barrow ME; Johnson JK
    Br J Anaesth; 1966 Jun; 38(6):420-31. PubMed ID: 5944020
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on performance with aspirin and paracetamol and with the centrally acting analgesics meptazinol and pentazocine.
    Bradley CM; Nicholson AN
    Eur J Clin Pharmacol; 1987; 32(2):135-9. PubMed ID: 3582476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress interacts with peripheral cholinesterase inhibitors to cause central nervous system effects.
    Beck KD; Brennan FX; Moldow RL; Ottenweller JE; Zhu G; Servatius RJ
    Life Sci; 2003 May; 73(1):41-51. PubMed ID: 12726885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The H1-antagonist mequitazine: studies on performance and visual function.
    Nicholson AN; Stone BM
    Eur J Clin Pharmacol; 1983; 25(4):563-6. PubMed ID: 6418550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
    Fleming NW; Lewis BK
    Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central effect of cholinesterase-inhibitor pyridostigmine].
    REITTER H
    Experientia; 1957 Jul; 13(7):296-7. PubMed ID: 13461863
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects on neuromuscular function of acute chronic exposure to cholinesterase inhibitors in man and in the rat.
    Roberts DV; Taylor K; Wilson A
    J Physiol; 1971 Dec; 219(2):15P. PubMed ID: 4333825
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensorimotor deficit and cholinergic changes following coexposure with pyridostigmine bromide and sarin in rats.
    Abou-Donia MB; Dechkovskaia AM; Goldstein LB; Bullman SL; Khan WA
    Toxicol Sci; 2002 Mar; 66(1):148-58. PubMed ID: 11861982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine.
    Alhalel A; Ziv I; Versano D; Ruach M; Alkalay M; Almog S; Izraeli S; Glovinsky J
    Aviat Space Environ Med; 1995 Nov; 66(11):1037-40. PubMed ID: 8588791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain.
    Amourette C; Lamproglou I; Barbier L; Fauquette W; Zoppe A; Viret R; Diserbo M
    Behav Brain Res; 2009 Nov; 203(2):207-14. PubMed ID: 19433115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration.
    Grauer E; Alkalai D; Kapon J; Cohen G; Raveh L
    Toxicol Appl Pharmacol; 2000 May; 164(3):301-4. PubMed ID: 10799340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
    Hindmarch I; Shamsi Z; Kimber S
    Clin Exp Allergy; 2002 Jan; 32(1):133-9. PubMed ID: 12002730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.